| Ana Chartier, MD | |
|
3122 E Meridian Park Loop Ste 2, Wasilla, AK 99654-7255 | |
| (907) 357-3133 | |
| (907) 357-9522 |
| Full Name | Ana Chartier |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 3122 E Meridian Park Loop Ste 2, Wasilla, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427408947 | NPI | - | NPPES |
| 1714577 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 163599 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Network Of Alaska Llc | 3072618859 | 61 |
News Archive
Global funding for malaria reached $1.7 billion in 2009, a "ten-fold" increase since 2004, and the production of insecticide-treated nets (ITNs) worldwide rose to 150 million last year, according to a report, released Monday, from UNICEF and the Roll Back Malaria (RBM) partnership, which also highlighted the need for additional funding, Agence France-Presse reports (4/19).
Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.
An engineering researcher and a global health expert from Michigan State University are working on bringing a low-cost, hand-held device to nations with limited resources to help physicians detect and diagnose cancer.
Nov. 1 marks the start of Open Enrollment for people buying their own coverage for 2019 in most states. Despite the turmoil surrounding the Affordable Care Act, most consumers will have more choices and mostly flat — and in some cases lower — premiums.
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia.
› Verified 4 days ago
| Entity Name | Center For Womens Health Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316035199 PECOS PAC ID: 5092602524 Enrollment ID: O20040301000624 |
News Archive
Global funding for malaria reached $1.7 billion in 2009, a "ten-fold" increase since 2004, and the production of insecticide-treated nets (ITNs) worldwide rose to 150 million last year, according to a report, released Monday, from UNICEF and the Roll Back Malaria (RBM) partnership, which also highlighted the need for additional funding, Agence France-Presse reports (4/19).
Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.
An engineering researcher and a global health expert from Michigan State University are working on bringing a low-cost, hand-held device to nations with limited resources to help physicians detect and diagnose cancer.
Nov. 1 marks the start of Open Enrollment for people buying their own coverage for 2019 in most states. Despite the turmoil surrounding the Affordable Care Act, most consumers will have more choices and mostly flat — and in some cases lower — premiums.
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia.
› Verified 4 days ago
| Entity Name | Medical Network Of Alaska Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538414834 PECOS PAC ID: 3072618859 Enrollment ID: O20070424000329 |
News Archive
Global funding for malaria reached $1.7 billion in 2009, a "ten-fold" increase since 2004, and the production of insecticide-treated nets (ITNs) worldwide rose to 150 million last year, according to a report, released Monday, from UNICEF and the Roll Back Malaria (RBM) partnership, which also highlighted the need for additional funding, Agence France-Presse reports (4/19).
Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.
An engineering researcher and a global health expert from Michigan State University are working on bringing a low-cost, hand-held device to nations with limited resources to help physicians detect and diagnose cancer.
Nov. 1 marks the start of Open Enrollment for people buying their own coverage for 2019 in most states. Despite the turmoil surrounding the Affordable Care Act, most consumers will have more choices and mostly flat — and in some cases lower — premiums.
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia.
› Verified 4 days ago
| Entity Name | Obhg Alaska Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740697069 PECOS PAC ID: 7113233834 Enrollment ID: O20150826000621 |
News Archive
Global funding for malaria reached $1.7 billion in 2009, a "ten-fold" increase since 2004, and the production of insecticide-treated nets (ITNs) worldwide rose to 150 million last year, according to a report, released Monday, from UNICEF and the Roll Back Malaria (RBM) partnership, which also highlighted the need for additional funding, Agence France-Presse reports (4/19).
Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.
An engineering researcher and a global health expert from Michigan State University are working on bringing a low-cost, hand-held device to nations with limited resources to help physicians detect and diagnose cancer.
Nov. 1 marks the start of Open Enrollment for people buying their own coverage for 2019 in most states. Despite the turmoil surrounding the Affordable Care Act, most consumers will have more choices and mostly flat — and in some cases lower — premiums.
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ana Chartier, MD 3505 E Meridian Park Loop Ste 100, Wasilla, AK 99654-7242 Ph: (907) 357-4963 | Ana Chartier, MD 3122 E Meridian Park Loop Ste 2, Wasilla, AK 99654-7255 Ph: (907) 357-3133 |
News Archive
Global funding for malaria reached $1.7 billion in 2009, a "ten-fold" increase since 2004, and the production of insecticide-treated nets (ITNs) worldwide rose to 150 million last year, according to a report, released Monday, from UNICEF and the Roll Back Malaria (RBM) partnership, which also highlighted the need for additional funding, Agence France-Presse reports (4/19).
Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.
An engineering researcher and a global health expert from Michigan State University are working on bringing a low-cost, hand-held device to nations with limited resources to help physicians detect and diagnose cancer.
Nov. 1 marks the start of Open Enrollment for people buying their own coverage for 2019 in most states. Despite the turmoil surrounding the Affordable Care Act, most consumers will have more choices and mostly flat — and in some cases lower — premiums.
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia.
› Verified 4 days ago
Donna Chester, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3505 E Meridian Park Loop, Suite 100, Wasilla, AK 99654 Phone: 907-279-2229 Fax: 907-357-1894 | |
John Oliver, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3750 E Country Field Cir Ste D, Wasilla, AK 99654 Phone: 907-357-6121 Fax: 907-357-6171 | |
Dr. Darryl G Elrod Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1301 W Parks Hwy Ste 101, Wasilla, AK 99654 Phone: 907-357-7781 Fax: 907-745-6573 | |
Dr. Ellen Dee Faucett, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3505 E Meridian Park Loop Ste 100, Wasilla, AK 99654 Phone: 907-357-4963 |